Lifestyle

[Blue Ocean Veterinary Medical Devices] (2) RAYENCE CO., LTD. Subsidiary Woori-En Holds Overwhelming Lead in the Veterinary Electronic Medical Record Market

Kim Jinsoo
2026-07-22 08:41:02
[Edaily Reporter Kim Jinsoo ] As medical technology advances, the treatment of human diseases is evolving toward “personalized” and “precision medicine.” Consequently, demand for personalized treatment and precision medicine is now extending to companion animals, which have recently come to be regarded as “family” members. Until now, animals have mostly relied on treatments and medical devices developed for humans, as there were no animal-specific options available. While this posed challenges—including cost burdens, product size limitations, and low accuracy—the introduction of animal-specific products has enhanced safety and enabled more precise treatment and diagnosis . In particular, by actively utilizing “technology transfer”—developing animal-specific products based on technologies originally applied to human products—companies have reduced R&D investment and risks while increasing profits. [Editor’s Note]

(Photo = AI-generated)

WooriEn: Differentiating Itself with Products Exclusively for Animals
Value Added Technology Co., Ltd.(043150)WooriEn, a grand-subsidiary of [Company Name] and a subsidiary of RAYENCE CO., LTD.(228850), launched a CT scanner and dental panoramic X-ray equipment exclusively for veterinary clinics in 2019. The “MyVet CT i3D” (hereinafter “MyVet CT”), a CT scanner designed specifically for veterinary clinics to diagnose cancer and tumors in animals, is replacing high-cost human-use CT scanners and leading the way toward the widespread adoption of veterinary CT.

MyVet CT not only replaces expensive human-use CT scanners but also offers the advantages of conventional MDCT—such as angiography and high-quality imaging for soft tissue diagnosis—while enhancing convenience.

Veterinary clinics require CT scans to diagnose tumors in animals’ organs, blood vessels, and muscles, but they have hesitated to adopt them due to the high cost of human-use CT scanners, as well as the burdens associated with electrical work, ancillary facilities, and the need for large spaces. Woori-N CT significantly lowers the barrier to adoption by offering the performance of human-use CT at a reasonable price—less than 50% of that of standard CT—along with a compact footprint, standard voltage requirements, and short scan times. This means that any clinic seeking to provide high-value-added care can adopt CT, regardless of its size.

In addition to the CT scanner, the world’s first veterinary-specific dental panoramic X-ray system introduced by WooriEn has revolutionized the paradigm of veterinary dental care. This veterinary-specific dental panoramic X-ray system minimizes imaging time, reducing discomfort for pets and enhancing convenience.

WooriEn’s strategy proved successful overseas as well. Immediately after launching its veterinary-exclusive CT and dental panoramic equipment, WooriEn entered the U.S. market, opening up a new market for veterinary-specific medical devices. Cumulative sales in the North American market have exceeded 50 billion won.

Subsequently, WooriEn developed an electronic medical record (EMR) cloud system for the era of smart veterinary clinics. “PMS 365 Cloud” stores data in the cloud, alleviating concerns about data loss, and enables mobile clinic management. WooriEn was the first company in Korea to commercialize a cloud-based clinic management system.

Prior to the launch of WooriEn’s PMS 365 Cloud, veterinary clinics relied on PC-based medical records, which could only be accessed within the clinic itself; when medical data was corrupted due to various errors, it was extremely difficult to recover. In contrast, WooriEn’s PMS 365 Cloud stores data on AWS (Amazon Web Services), the world’s largest cloud service provider. This not only allows users to access medical records remotely but also provides protection against data loss and security issues.

WooriEn’s cloud EMR technology has recently become even more competitive with the addition of its proprietary AI technology. In April of this year, WooriEn officially launched an AI-based clinical support platform that automates medical records and generates health screening reports. This is significant because, as it is based on data accumulated in the cloud EMR, it represents a result achieved through the company’s own technological capabilities rather than a simple adoption of existing technology.

In 2025, WooriEn recorded consolidated revenue of 34.5 billion won and an operating profit of 470 million won. This marks a simultaneous achievement of revenue growth and improved profitability compared to 2024’s revenue of 27.8 billion won and operating loss of 340 million won, successfully turning the company into the black.

A WOORIRO CO., LTD official stated, “The cloud-based electronic medical record system, which we were the first in Korea to introduce, maintains its position as the undisputed market leader in the domestic veterinary cloud EMR market.”

WooriEn’s Products Utilize Detectors from Parent Company RAYENCE
CO., LTD. RAYENCE CO., LTD. and WooriEn are cited as prime examples of “vertical integration” and “technology transfer.” RAYENCE CO., LTD. specializes in X-ray imaging device detectors and holds proprietary core technologies for cone beam (CBCT) CT—the first in Korea to use a flat-panel detector—and dental CT image reconstruction algorithms. Based on this technology, the company is expanding its product line to include medical, dental, veterinary, and industrial X-ray detectors.

Furthermore, the veterinary CT scanners and dental panoramic scanners developed and manufactured by Woori-En are all produced using RAYENCE CO., LTD. detectors. RAYENCE CO., LTD. detectors are capable of generating high-efficiency, high-resolution images.

Value Added Technology Co., Ltd., which is Rayance’s parent company, also sources detectors—a core component of CT systems—from Rayance. Since products are manufactured and supplied internally, this not only helps improve profit margins by reducing transaction costs but also enhances production efficiency by enabling the entire process, from manufacturing to distribution, to be handled in-house.

Furthermore, based on Value Added Technology Co., Ltd.’s strengths in the dental medical device sector, the company is already considered to possess overwhelming competitiveness in the field of veterinary dental imaging equipment.

WooriEn is preparing to expand into new businesses by leveraging its strength as the market leader in veterinary EMR and its AI capabilities. Regarding its global expansion, the company is increasing exports to North America and Europe.

A WooriEn official stated, “We already hold the No. 1 position in the U.S. market for X-ray sensors for veterinary oral imaging and non-oral X-ray imaging equipment, so the foundation for expanding our market presence is already in place,” adding, “By achieving simultaneous profitability in both businesses and leveraging our AI technology competitiveness, we will usher in a new paradigm for veterinary medical devices.”

Economy

Corporation

IT·Science

Economy

SP SAMHWA Supports Mural Project in Seonsan-eup, Gumi, with Students from Seoul Institute of the Arts

SamhwaPaintIndustrial(000390)(formerly Samhwa Paint Industry), a comprehensive chemical materials company, has stepped up to support the creative activities of young artists and improve the local envi…
2026-07-22 09:05:20

Corporation

KOLMAR KOREA Yoonwoo Shares Strategy for Addressing European Packaging Regulations

Yonwoo, a subsidiary of KOLMAR KOREA(161890) and a cosmetics packaging manufacturer, announced on the 22nd that it had successfully concluded the “Packaging Megatrends and Global Quality Strategy Semi…
2026-07-22 09:08:30

IT·Science

Alteogen Inc., Which Aimed for a '30 Trillion Valuation,' Remains on KOSDAQ After 7 Months… Beneficiaries of the Promotion-Demotion System

Alteogen Inc.(196170), the company with the largest market capitalization on KOSDAQ, has tentatively put on hold its plans to relist on the Korea Exchange (KOSPI) and opted to remain on KOSDAQ. This c…
2026-07-22 08:42:02